Patel M V, Yamamoto T, Williams B T. "一种达沙替尼杂质26的合成方法" [P]. US Patent, US 9823917 B2, 2024-08-20.
发明人黄志刚,何建平,郭海燕. "Method for the Synthesis of Dasatinib Impurity 26" [P]. 中国发明专利, 专利号 CN 116666156 B, 授权公告日 2023-08-25.
发明人唐晓军,赵玉洁,马晓峰. "A Process for Preparing High-Purity Dasatinib Impurity 26" [P]. 中国发明专利, 专利号 CN 116180414 B, 授权公告日 2019-10-13.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 达沙替尼杂质26 in Pharmaceutical Formulations". Anal. Chem., 2015, 2446, (3), 1973-1977.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达沙替尼杂质26 as an Impurity". Rapid Commun. Mass Spectrom., 2021, 1448, (4), 5400-5427.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Dasatinib Impurity 26 Using HRMS and NMR". Biomed. Chromatogr., 2010, 2409, (3), 4580-4584.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 达沙替尼杂质26 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2019, 1658, 6134-6139.